Global Organ Transplant Rejection Medication Market Valued at USD 4.9 Billion in 2022, Poised for Growth
The global organ transplant rejection medication market was valued at USD 4.9 billion in 2022 and is projected to surpass USD 7.0 billion by 2031, expanding at a CAGR of 3.9% from 2023 to 2031. Market growth is driven by the rising number of organ transplant procedures, increasing prevalence of chronic diseases leading to organ failure, growing demand for immunosuppressive therapies, and...
0 Comments 0 Shares 13 Views 0 Reviews
MakeMyFriends https://makemyfriends.com